Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan

Nat Commun. 2021 Aug 5;12(1):4846. doi: 10.1038/s41467-021-25109-1.

Cesheng Li^#¹, Ding Yu^#^{2

3}, Xiao Wu¹, Hong Liang^{2

3}, Zhijun Zhou¹, Yong Xie^{1

3}, Taojing Li³, Junzheng Wu², Fengping Lu¹, Lu Feng¹, Min Mao¹, Lianzhen Lin¹, Huanhuan Guo¹, Shenglan Yue¹, Feifei Wang¹, Yan Peng¹, Yong Hu¹, Zejun Wang⁴, Jianhong Yu¹, Yong Zhang³, Jia Lu⁴, Haoran Ning¹, Huichuan Yang⁵, Daoxing Fu³, Yanlin He^{1

3}, Dongbo Zhou³, Tao Du³, Kai Duan⁴, Demei Dong³, Kun Deng¹, Xia Zou¹, Ya Zhang¹, Rong Zhou³, Yang Gao³, Xinxin Zhang⁶, Xiaoming Yang⁷

¹ Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.
² Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.
³ Beijing Tiantan Biological Products Co., Ltd, Beijing, China.
⁴ Wuhan Institute of Biological Products Co. Ltd, Wuhan, China.
⁵ China National Biotec Group Company Limited, Beijing, China.
⁶ Research Laboratory of Clinical Virology, Ruijin Hospital and Ruijin Hospital North, National Research Center for Translational Medicine, Shanghai Jiao Tong University of Medicine, Shanghai, China. zhangx@shsmu.edu.cn.
⁷ China National Biotec Group Company Limited, Beijing, China. yangxiaoming@sinopharm.com.

^# Contributed equally.

No abstract available

Publication types